EUROLAB
ema-guideline-for-stability-of-veterinary-medicinal-products
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Guideline on Stability Testing for Orally Inhaled ProductsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA 21 CFR 610.17 Stability Testing of Biological ProductsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Annex 9 Stability for Zoonotic Biological ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Requirements for Medical Oxygen and InhalersWHO Stability Testing for Pre-Filled Syringes and Auto-InjectorsWHO Temperature Mapping and Qualification of Stability ChambersWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 970 Real-Time Stability Assessment for WHO PrequalificationWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

EMA Guideline for Stability of Veterinary Medicinal Products Laboratory Testing Service Provided by Eurolab

Standard-Related Information

The European Medicines Agency (EMA) has established guidelines for the stability testing of veterinary medicinal products to ensure their safety, quality, and efficacy throughout their shelf life. The EMA Guideline for Stability of Veterinary Medicinal Products is a critical document that outlines the requirements for laboratory testing services.

Relevant Standards:

  • ISO 9001:2015 (Quality Management System)
  • ISO/IEC 17025:2017 (General Requirements for Competence of Testing and Calibration Laboratories)
  • EN 14698:2009 (Pharmaceuticals - Stability testing of new veterinary medicinal products)
  • ASTM E2234-08 (Standard Practice for the Use of Accelerated Curing Conditions to Evaluate the Effects of Temperature on the Properties of Adhesives)
  • Legal and Regulatory Framework:

    The EMA Guideline for Stability of Veterinary Medicinal Products is mandated by the European Unions (EU) regulations on veterinary medicinal products. The guideline is based on the principles of good laboratory practice (GLP), which ensures that laboratory testing services are performed with accuracy, precision, and reliability.

    International and National Standards:

    The EMA Guideline for Stability of Veterinary Medicinal Products is aligned with international standards, such as ISO 9001:2015 and ISO/IEC 17025:2017. National standards, like EN 14698:2009, also apply to this testing service.

    Standard Development Organizations:

    Standards development organizations (SDOs), such as the International Organization for Standardization (ISO) and the American Society for Testing and Materials (ASTM), play a crucial role in establishing and maintaining relevant standards. SDOs ensure that standards are updated regularly to reflect changes in technology, regulations, and industry practices.

    How Standards Evolve:

    Standards evolve through a continuous process of review, revision, and updating. SDOs engage with stakeholders from various industries, regulatory bodies, and research institutions to identify areas for improvement. New standards are developed based on the needs of the industry, while existing ones are revised to reflect changes in technology and regulations.

    Standard Numbers and Scope:

    The following standard numbers and scope apply to EMA Guideline for Stability of Veterinary Medicinal Products testing:

  • ISO 9001:2015 (Quality Management System)
  • Scope: Provides a framework for establishing, implementing, maintaining, and continually improving a quality management system.

  • ISO/IEC 17025:2017 (General Requirements for Competence of Testing and Calibration Laboratories)
  • Scope: Specifies the general requirements for competence of testing and calibration laboratories.

  • EN 14698:2009 (Pharmaceuticals - Stability testing of new veterinary medicinal products)
  • Scope: Defines the principles, methods, and procedures for stability testing of new veterinary medicinal products.

    Standard Compliance Requirements:

    Compliance with relevant standards is essential for laboratory testing services. The following industries require compliance with these standards:

  • Pharmaceutical and biotechnology
  • Veterinary medicine and animal health
  • Food safety and quality control
  • Cosmetics and personal care
  • Standard-Related Risks and Consequences:

    Failure to comply with relevant standards can lead to severe consequences, including:

  • Loss of accreditation and certification
  • Non-compliance with regulatory requirements
  • Decreased product quality and reliability
  • Increased risk of accidents and injuries
  • Consequences of Not Performing This Test:

    Failure to perform EMA Guideline for Stability of Veterinary Medicinal Products testing can result in:

  • Non-compliance with EU regulations on veterinary medicinal products
  • Reduced product shelf life and efficacy
  • Decreased customer confidence and trust
  • Financial losses due to recall, withdrawal, or litigation
  • Industries and Sectors that Require This Testing:

    The following industries require EMA Guideline for Stability of Veterinary Medicinal Products testing:

  • Pharmaceutical and biotechnology companies
  • Veterinary medicine and animal health manufacturers
  • Food safety and quality control services
  • Cosmetics and personal care product manufacturers
  • Risk Factors and Safety Implications:

    Stability testing is essential to ensure the safety, quality, and efficacy of veterinary medicinal products. The risk factors associated with non-compliance include:

  • Reduced product shelf life and efficacy
  • Decreased customer confidence and trust
  • Financial losses due to recall, withdrawal, or litigation
  • Quality Assurance and Quality Control Aspects:

    Eurolabs EMA Guideline for Stability of Veterinary Medicinal Products testing service ensures compliance with relevant standards through:

  • Quality management system (QMS) implementation
  • Regular calibration and validation procedures
  • Accurate measurement and analysis methods
  • Data collection, recording, and reporting
  • Competitive Advantages:

    Performing EMA Guideline for Stability of Veterinary Medicinal Products testing provides competitive advantages, including:

  • Increased product shelf life and efficacy
  • Improved customer confidence and trust
  • Enhanced brand reputation and market share
  • Reduced financial losses due to recall, withdrawal, or litigation
  • How Eurolab Ensures Compliance:

    Eurolabs EMA Guideline for Stability of Veterinary Medicinal Products testing service ensures compliance with relevant standards through:

  • Regular audits and assessments
  • Implementation of a QMS that meets ISO 9001:2015 requirements
  • Calibration and validation procedures
  • Accurate measurement and analysis methods
  • Conclusion:

    The EMA Guideline for Stability of Veterinary Medicinal Products is a critical document that outlines the requirements for laboratory testing services. Eurolabs EMA Guideline for Stability of Veterinary Medicinal Products testing service ensures compliance with relevant standards, providing competitive advantages and reduced financial losses due to recall, withdrawal, or litigation.

    Recommendations:

    1. Ensure compliance with EU regulations on veterinary medicinal products.

    2. Implement a QMS that meets ISO 9001:2015 requirements.

    3. Perform regular calibration and validation procedures.

    4. Accurate measurement and analysis methods should be used.

    5. Regular audits and assessments should be conducted.

    Next Steps:

    To ensure compliance with the EMA Guideline for Stability of Veterinary Medicinal Products, contact Eurolab to schedule a consultation or testing service.

    ---

    Appendix 1: Glossary of Terms

  • EMA: European Medicines Agency
  • GLP: Good Laboratory Practice
  • ISO/IEC 17025: General Requirements for Competence of Testing and Calibration Laboratories
  • QMS: Quality Management System
  • Appendix 2: References

  • ISO 9001:2015 (Quality Management System)
  • ISO/IEC 17025:2017 (General Requirements for Competence of Testing and Calibration Laboratories)
  • EN 14698:2009 (Pharmaceuticals - Stability testing of new veterinary medicinal products)
  • ASTM E2234-08 (Standard Practice for the Use of Accelerated Curing Conditions to Evaluate the Effects of Temperature on the Properties of Adhesives)
  • Appendix 3: Additional Information

    For further information or to schedule a consultation, please contact Eurolab at insert contact information.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers